Huayuan Liu

Jinan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

The mechanism and application of Scrophulariae Radix in the treatment of endocrine disorders: focusing on thyroid diseases and diabetes mellitus.

The mechanism and application of Scrophulariae Radix in the treatment of endocrine disorders: focusing on thyroid diseases and diabetes mellitus.

Journal: Frontiers in endocrinology
Published: August 13, 2025

Targeting ferroptosis and mitochondrial abnormalities: a promising therapeutic strategy for diabetes and its complications.

Targeting ferroptosis and mitochondrial abnormalities: a promising therapeutic strategy for diabetes and its complications.

Journal: Life sciences
Published: July 25, 2025

Author Correction: Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.

Author Correction: Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.

Journal: Scientific reports
Published: May 27, 2025

Shuyu capsule alleviates premenstrual depression via allopregnanolone metabolic pathway targeting GABA (A) receptors δ subunit in the hippocampus.

Shuyu capsule alleviates premenstrual depression via allopregnanolone metabolic pathway targeting GABA (A) receptors δ subunit in the hippocampus.

Journal: Asian journal of psychiatry
Published: September 15, 2023

Correction to: Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.

Correction to: Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.

Journal: Archives of gynecology and obstetrics
Published: September 07, 2022

Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.

Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.

Journal: Archives of gynecology and obstetrics
Published: June 15, 2021

Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.

Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.

Journal: Scientific reports
Published: May 19, 2021

Gynecological acute abdomen in patients age under 18: an analysis of 237 cases

Gynecological acute abdomen in patients age under 18: an analysis of 237 cases

Journal: Zhonghua fu chan ke za zhi
Published: May 28, 2018
Showing 1-8 of 8

Last Updated: 09/26/2026